0001209191-21-057450.txt : 20210923
0001209191-21-057450.hdr.sgml : 20210923
20210923170033
ACCESSION NUMBER: 0001209191-21-057450
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210921
FILED AS OF DATE: 20210923
DATE AS OF CHANGE: 20210923
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SHERMAN JEFFREY W
CENTRAL INDEX KEY: 0001230482
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35238
FILM NUMBER: 211273109
MAIL ADDRESS:
STREET 1: C/O IDM PHARMA, INC.
STREET 2: 9 PARKER, SUITE 100
CITY: IRVINE
STATE: CA
ZIP: 92618
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Horizon Therapeutics Public Ltd Co
CENTRAL INDEX KEY: 0001492426
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L2
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: CONNAUGHT HOUSE, 1ST FLOOR
STREET 2: 1 BURLINGTON ROAD
CITY: DUBLIN
STATE: L2
ZIP: 4
BUSINESS PHONE: 011-353-1-772-2100
MAIL ADDRESS:
STREET 1: CONNAUGHT HOUSE, 1ST FLOOR
STREET 2: 1 BURLINGTON ROAD
CITY: DUBLIN
STATE: L2
ZIP: 4
FORMER COMPANY:
FORMER CONFORMED NAME: Horizon Pharma plc
DATE OF NAME CHANGE: 20140919
FORMER COMPANY:
FORMER CONFORMED NAME: HORIZON PHARMA, INC.
DATE OF NAME CHANGE: 20100520
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-09-21
0
0001492426
Horizon Therapeutics Public Ltd Co
HZNP
0001230482
SHERMAN JEFFREY W
C/O HORIZON THERAPEUTICS PLC
CONNAUGHT HOUSE, 1ST FL, 1 BURLINGTON RD
DUBLIN
L2
4
IRELAND
0
1
0
0
EVP and Chief Medical Officer
Ordinary Shares
2021-09-03
5
G
0
E
4042
0.00
D
9115
D
Ordinary Shares
2021-09-03
5
G
0
E
4042
0.00
A
27079
I
See footnote
Ordinary Shares
2021-09-21
4
M
0
46271
7.61
A
55386
D
Ordinary Shares
2021-09-21
4
S
0
46271
110.00
D
9115
D
Ordinary Shares
66730
I
By Spouse
Ordinary Shares
105808
I
See footnote
Stock Option (Right to Buy)
7.61
2021-09-21
4
M
0
46271
0.00
D
2024-01-02
Ordinary Shares
46271
10729
D
The shares are held in the Jeffrey W. Sherman Living Trust.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 10, 2021.
The shares are held in the name of the Jeffrey W. Sherman 2020 Gift Trust, of which the reporting person's spouse is the Trustee.
The stock option is fully vested and exercisable.
/s/ Miles W. McHugh, Attorney-in-Fact
2021-09-23